Search research articles
Contact Us
Filters
Showing results (31-40 of 122) with videos related to
Page
of 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2008
Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using national cancer institute expanded common toxicity criteria
Richard Choo, Maria Pearse, Cyril Danjoux, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 5, 2009
Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse
Richard Choo, Cyril Danjoux, Sandra Gardner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 19, 2019
Postimplant Dosimetry of Permanent Prostate Brachytherapy: Comparison of MRI-Only and CT-MRI Fusion-Based Workflows
Reyhaneh Nosrati, Matthew Wronski, Chia-Lin Tseng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 28, 2006
Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy
Andrew Pearce, Richard Choo, Cyril Danjoux, et al.
Brachytherapy
|
December 4, 2014
The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer
Laura D'Alimonte, Joelle Helou, Christopher Sherman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 23, 2002
Urodynamic changes at 18 months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma
Richard Choo, Viet Do, Sender Herschorn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 4, 2020
Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis
Lucas C Mendez, Kevin Martell, Andrew Warner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 7, 2005
Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery
Sarat Chander, Richard Choo, Cyril Danjoux, et al.
The Canadian Journal of Urology
|
March 22, 2005
How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?
Richard Choo, Sarat Chander, Cyril Danjoux, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2006
Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05)
Colleen A Lawton, Michelle DeSilvio, W Robert Lee, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 122) with videos related to
Sort By:
Page
of 13
International Journal of Radiation Oncology, Biology, Physics
|
April 26, 2008
Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using national cancer institute expanded common toxicity criteria
Richard Choo, Maria Pearse, Cyril Danjoux, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 5, 2009
Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse
Richard Choo, Cyril Danjoux, Sandra Gardner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 19, 2019
Postimplant Dosimetry of Permanent Prostate Brachytherapy: Comparison of MRI-Only and CT-MRI Fusion-Based Workflows
Reyhaneh Nosrati, Matthew Wronski, Chia-Lin Tseng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 28, 2006
Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy
Andrew Pearce, Richard Choo, Cyril Danjoux, et al.
Brachytherapy
|
December 4, 2014
The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer
Laura D'Alimonte, Joelle Helou, Christopher Sherman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 23, 2002
Urodynamic changes at 18 months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma
Richard Choo, Viet Do, Sender Herschorn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 4, 2020
Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis
Lucas C Mendez, Kevin Martell, Andrew Warner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 7, 2005
Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery
Sarat Chander, Richard Choo, Cyril Danjoux, et al.
The Canadian Journal of Urology
|
March 22, 2005
How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?
Richard Choo, Sarat Chander, Cyril Danjoux, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2006
Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05)
Colleen A Lawton, Michelle DeSilvio, W Robert Lee, et al.
Page
of 13